196 related articles for article (PubMed ID: 29434030)
1. Src-mediated phosphorylation converts FHL1 from tumor suppressor to tumor promoter.
Wang X; Wei X; Yuan Y; Sun Q; Zhan J; Zhang J; Tang Y; Li F; Ding L; Ye Q; Zhang H
J Cell Biol; 2018 Apr; 217(4):1335-1351. PubMed ID: 29434030
[TBL] [Abstract][Full Text] [Related]
2. Four and a half LIM domains protein 1 can be as a double-edged sword in cancer progression.
Wei X; Zhang H
Cancer Biol Med; 2020 May; 17(2):270-281. PubMed ID: 32587768
[TBL] [Abstract][Full Text] [Related]
3. SRC uses Cas to suppress Fhl1 in order to promote nonanchored growth and migration of tumor cells.
Shen Y; Jia Z; Nagele RG; Ichikawa H; Goldberg GS
Cancer Res; 2006 Feb; 66(3):1543-52. PubMed ID: 16452211
[TBL] [Abstract][Full Text] [Related]
4. X-linked FHL1 as a novel therapeutic target for head and neck squamous cell carcinoma.
Cao W; Liu J; Xia R; Lin L; Wang X; Xiao M; Zhang C; Li J; Ji T; Chen W
Oncotarget; 2016 Mar; 7(12):14537-50. PubMed ID: 26908444
[TBL] [Abstract][Full Text] [Related]
5. FHL1 inhibits the growth of tongue squamous cell carcinoma cells via G1/S cell cycle arrest.
Ren W; Lian P; Cheng L; Du P; Guan X; Wang H; Ding L; Gao Z; Huang X; Xiao F; Wang L; Bi X; Ye Q; Wang E
Mol Med Rep; 2015 Sep; 12(3):3958-3964. PubMed ID: 26017856
[TBL] [Abstract][Full Text] [Related]
6. Coordinate suppression of Sdpr and Fhl1 expression in tumors of the breast, kidney, and prostate.
Li X; Jia Z; Shen Y; Ichikawa H; Jarvik J; Nagele RG; Goldberg GS
Cancer Sci; 2008 Jul; 99(7):1326-33. PubMed ID: 18422756
[TBL] [Abstract][Full Text] [Related]
7. FHL1 promotes glioblastoma aggressiveness through regulating EGFR expression.
Sun L; Chen L; Zhu H; Li Y; Chen CC; Li M
FEBS Lett; 2021 Jan; 595(1):85-98. PubMed ID: 33053208
[TBL] [Abstract][Full Text] [Related]
8. Expression and Predictive Significance of FHL1 and SLIT3 in Surgically Resected Lung Adenocarcinoma.
Song J; Liang K; Wei T; Li L; Huang Z; Chen G; Mao N; Yang J
Comb Chem High Throughput Screen; 2023; 26(12):2226-2237. PubMed ID: 36752296
[TBL] [Abstract][Full Text] [Related]
9. FHL1 and Smad4 synergistically inhibit vascular endothelial growth factor expression.
Zhou Z; Lu J; Dou J; Lv Z; Qin X; Lin J
Mol Med Rep; 2013 Feb; 7(2):649-53. PubMed ID: 23184087
[TBL] [Abstract][Full Text] [Related]
10. Structural and Functional Characterization of Host FHL1 Protein Interaction with Hypervariable Domain of Chikungunya Virus nsP3 Protein.
Lukash T; Agback T; Dominguez F; Shiliaev N; Meshram C; Frolova EI; Agback P; Frolov I
J Virol; 2020 Dec; 95(1):. PubMed ID: 33055253
[TBL] [Abstract][Full Text] [Related]
11. Expression of FHL1 in gastric cancer tissue and its correlation with the invasion and metastasis of gastric cancer.
Xu Y; Liu Z; Guo K
Mol Cell Biochem; 2012 Apr; 363(1-2):93-9. PubMed ID: 22143536
[TBL] [Abstract][Full Text] [Related]
12. Identification of FHL1 as a therapeutic target for Duchenne muscular dystrophy.
D'Arcy CE; Feeney SJ; McLean CA; Gehrig SM; Lynch GS; Smith JE; Cowling BS; Mitchell CA; McGrath MJ
Hum Mol Genet; 2014 Feb; 23(3):618-36. PubMed ID: 24087791
[TBL] [Abstract][Full Text] [Related]
13. Kindlin-2 phosphorylation by Src at Y193 enhances Src activity and is involved in Migfilin recruitment to the focal adhesions.
Liu Z; Lu D; Wang X; Wan J; Liu C; Zhang H
FEBS Lett; 2015 Jul; 589(15):2001-10. PubMed ID: 26037143
[TBL] [Abstract][Full Text] [Related]
14. CpG hypermethylation of human four-and-a-half LIM domains 1 contributes to migration and invasion activity of human bladder cancer.
Matsumoto M; Kawakami K; Enokida H; Toki K; Matsuda R; Chiyomaru T; Nishiyama K; Kawahara K; Seki N; Nakagawa M
Int J Mol Med; 2010 Aug; 26(2):241-7. PubMed ID: 20596604
[TBL] [Abstract][Full Text] [Related]
15. FHL family members suppress vascular endothelial growth factor expression through blockade of dimerization of HIF1α and HIF1β.
Lin J; Qin X; Zhu Z; Mu J; Zhu L; Wu K; Jiao H; Xu X; Ye Q
IUBMB Life; 2012 Nov; 64(11):921-30. PubMed ID: 23086815
[TBL] [Abstract][Full Text] [Related]
16. FHL1 on chromosome X is a single-hit gastrointestinal tumor-suppressor gene and contributes to the formation of an epigenetic field defect.
Asada K; Ando T; Niwa T; Nanjo S; Watanabe N; Okochi-Takada E; Yoshida T; Miyamoto K; Enomoto S; Ichinose M; Tsukamoto T; Ito S; Tatematsu M; Sugiyama T; Ushijima T
Oncogene; 2013 Apr; 32(17):2140-9. PubMed ID: 22689052
[TBL] [Abstract][Full Text] [Related]
17. Immortalization-upregulated protein promotes pancreatic cancer progression by regulating NPM1/FHL1-mediated cell-cycle-checkpoint protein activity.
Luo Q; Pan Y; Fu Q; Zhang X; Zhou S; Yu P; Tian H; Liu P; Chen S; Zhang H; Qin T
Cell Biol Toxicol; 2023 Oct; 39(5):2069-2087. PubMed ID: 35142956
[TBL] [Abstract][Full Text] [Related]
18. PINCH-1 regulates mitochondrial dynamics to promote proline synthesis and tumor growth.
Guo L; Cui C; Wang J; Yuan J; Yang Q; Zhang P; Su W; Bao R; Ran J; Wu C
Nat Commun; 2020 Oct; 11(1):4913. PubMed ID: 33004813
[TBL] [Abstract][Full Text] [Related]
19. A novel mechanism involving four-and-a-half LIM domain protein-1 and extracellular signal-regulated kinase-2 regulates titin phosphorylation and mechanics.
Raskin A; Lange S; Banares K; Lyon RC; Zieseniss A; Lee LK; Yamazaki KG; Granzier HL; Gregorio CC; McCulloch AD; Omens JH; Sheikh F
J Biol Chem; 2012 Aug; 287(35):29273-84. PubMed ID: 22778266
[TBL] [Abstract][Full Text] [Related]
20. Kindlin-2 regulates mesenchymal stem cell differentiation through control of YAP1/TAZ.
Guo L; Cai T; Chen K; Wang R; Wang J; Cui C; Yuan J; Zhang K; Liu Z; Deng Y; Xiao G; Wu C
J Cell Biol; 2018 Apr; 217(4):1431-1451. PubMed ID: 29496737
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
